NFJ Investment Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
NFJ Investment Group's PFE Position: Q1 2026 in Review
NFJ Investment Group reduced its Pfizer (PFE) stake by 36% in Q1 2026, selling an estimated $20.9M and leaving 1,398,757 shares worth $39.3M. The position accounts for 1.49% of the portfolio, ranked #17.
NFJ Investment Group first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. The position peaked at $59.5M in Q3 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- NFJ Investment Group held 1,398,757 shares of Pfizer worth $39.3M as of Q1 2026.
- NFJ Investment Group sold 783,593 Pfizer shares in Q1 2026, an estimated $20.9M.
- Pfizer made up 1.49% of NFJ Investment Group's portfolio in Q1 2026, its #17 holding.
- NFJ Investment Group first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
- NFJ Investment Group's Pfizer position peaked at $59.5M in Q3 2025.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.